Drug Shortage Report for ODAN PROCTOMYXIN HC SUPPOSITORIES
| Report ID | 3885 |
| Drug Identification Number | 02242528 |
| Brand name | SANDOZ PROCTOMYXIN HC SUPPOSITORIES |
| Common or Proper name | PROCTOMYXIN |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN |
| Strength(s) | 5MG 5MG 10MG 10MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL |
| Packaging size | 12 |
| ATC code | C05AA |
| ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-21 |
| Estimated end date | 2017-04-07 |
| Actual end date | 2017-03-23 |
| Shortage status | Resolved |
| Updated date | 2017-03-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-03-28 | French | Compare |
| v3 | 2017-03-28 | English | Compare |
| v2 | 2017-03-21 | French | Compare |
| v1 | 2017-03-21 | English | Compare |
Showing 1 to 4 of 4